These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 11175399)

  • 1. Reinforcing and subjective effects of oral tripelennamine in normal human volunteers.
    Stern KN; Chait LD; Johanson CE
    Behav Pharmacol; 1989; 1(2):161-167. PubMed ID: 11175399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reinforcing and subjective effects of several anorectics in normal human volunteers.
    Chait LD; Uhlenhuth EH; Johanson CE
    J Pharmacol Exp Ther; 1987 Sep; 242(3):777-83. PubMed ID: 3656112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the reinforcing and subjective effects of d-amphetamine in humans.
    Chait LD
    Behav Pharmacol; 1993 Jun; 4(3):191-199. PubMed ID: 11224186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reinforcing and subjective effects of caffeine in normal human volunteers.
    Stern KN; Chait LD; Johanson CE
    Psychopharmacology (Berl); 1989; 98(1):81-8. PubMed ID: 2498963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinforcing effects of caffeine in humans.
    Griffiths RR; Woodson PP
    J Pharmacol Exp Ther; 1988 Jul; 246(1):21-9. PubMed ID: 3392652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol reduces stimulant and reinforcing effects of ethanol in social drinkers.
    Enggasser JL; de Wit H
    Alcohol Clin Exp Res; 2001 Oct; 25(10):1448-56. PubMed ID: 11696664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
    Zacny JP; Gutierrez S
    Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between naltrexone and oral THC in heavy marijuana smokers.
    Haney M; Bisaga A; Foltin RW
    Psychopharmacology (Berl); 2003 Feb; 166(1):77-85. PubMed ID: 12491025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further studies on the discriminative stimulus effects of diazepam in humans.
    Johanson CE
    Behav Pharmacol; 1991 Nov; 2(4 And 5):357-367. PubMed ID: 11224079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers.
    Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2003 Jan; 165(3):280-90. PubMed ID: 12434259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug preferences in humans.
    Johanson CE; Uhlenhuth EH
    Fed Proc; 1982 Feb; 41(2):228-33. PubMed ID: 7060750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug preference in humans: double-blind choice comparison of pentobarbital, diazepam and placebo.
    Griffiths RR; Bigelow GE; Liebson I; Kaliszak JE
    J Pharmacol Exp Ther; 1980 Dec; 215(3):649-61. PubMed ID: 7441524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of pharmacokinetics and pharmacodynamic effects related to abuse potential of a unique oral osmotic-controlled extended-release methylphenidate formulation in humans.
    Parasrampuria DA; Schoedel KA; Schuller R; Gu J; Ciccone P; Silber SA; Sellers EM
    J Clin Pharmacol; 2007 Dec; 47(12):1476-88. PubMed ID: 17962423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylpropanolamine: reinforcing and subjective effects in normal human volunteers.
    Chait LD; Uhlenhuth EH; Johanson CE
    Psychopharmacology (Berl); 1988; 96(2):212-7. PubMed ID: 3148148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nighttime versus daytime hypnotic self-administration.
    Roehrs T; Bonahoom A; Pedrosi B; Zorick F; Roth T
    Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice.
    Troisi 2nd JR; Critchfield TS; Griffiths RR
    Behav Pharmacol; 1993 Jun; 4(3):217-230. PubMed ID: 11224189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the subjective, psychomotor and reinforcing effects of nitrous oxide in healthy volunteers: a dose-response analysis.
    Zacny JP; Lichtor JL; Coalson DW; Alessi R; Goldsher G; Young CJ; Apfelbaum JL; Conley KM
    Behav Pharmacol; 1996 Mar; 7(2):194-199. PubMed ID: 11224411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ethanol choice in social drinkers following ethanol preload.
    de Wit H; Chutuape MA
    Behav Pharmacol; 1993 Feb; 4(1):29-36. PubMed ID: 11224168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.